Children's Tumor Foundation and Its Focus on Neurofibromatosis

Dr. Annette Bakker, CEO of Children's Tumor Foundation, Explains the Importance of Pediatric PRVsПодробнее

Children's Tumor Foundation HackathonПодробнее

NF Summit 2022: Genetics 101 and VCEP/Genetic Modifiers and Cutaneous NeurofibromasПодробнее

NF in Focus: Conversations that Matter with JasmineПодробнее

NF in Focus: Conversations that Matter with JanuПодробнее

NF in Focus: The Importance of Breast Screenings for women with NF1Подробнее

NF Forum 2020: The Impact of NF1 on Relationships, Learning, and SchoolПодробнее

Hack4Rare 2021 Final Ceremony and Winners PresentationПодробнее

Children's Tumor Foundation Preclinical HubПодробнее

Connecting the Unconnected to End NFПодробнее

Sel-u-bration! Children's Tumor Foundation Celebrates the First FDA Approval for NeurofibromatosisПодробнее

NF Data Hackathon - San Francisco 2019Подробнее

Children's Tumor Foundation NF ConferenceПодробнее

Children's Tumor Foundation and Its Focus on NeurofibromatosisПодробнее

The Children's Tumor Foundation Research ProgramПодробнее

The Latest "Behind the Buzz" Show: Featuring Children’s Tumor Foundation President Annette BakkerПодробнее

Tumor Talk: Living with Obvious Signs of NF1Подробнее

Virtual Panel Discussion: Focused Ultrasound’s Potential Role in Neurofibromatosis TreatmentПодробнее

Kenneth Rudd Shares His Story About Living with Neurofibromatosis Type 1Подробнее

Children's Wisconsin Neurofibromatosis Family SymposiumПодробнее